Lukacova E, Hanzlikova Z, Podlesnyi P, Sedlackova T, Szemes T, Grendar M
Sci Rep. 2024; 14(1):15786.
PMID: 38982214
PMC: 11233564.
DOI: 10.1038/s41598-024-65928-y.
Salachan P, Ulhoi B, Borre M, Sorensen K
Sci Rep. 2023; 13(1):22445.
PMID: 38105358
PMC: 10725894.
DOI: 10.1038/s41598-023-49811-w.
Poell J, Wils L, Brink A, Dietrich R, Krieg C, Velleuer E
Int J Cancer. 2022; 152(2):227-238.
PMID: 36069231
PMC: 9826173.
DOI: 10.1002/ijc.34277.
Frigola J, Carbonell C, Irazno P, Pardo N, Callejo A, Cedres S
J Immunother Cancer. 2022; 10(4).
PMID: 35477861
PMC: 9047699.
DOI: 10.1136/jitc-2021-004197.
Sabatier R, Vicier C, Garnier S, Guille A, Carbuccia N, Isambert N
Mol Oncol. 2022; 16(10):2057-2070.
PMID: 35122700
PMC: 9120890.
DOI: 10.1002/1878-0261.13188.
Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma.
Guan B, Liang Y, Lu H, Xu Z, Shi Y, Li J
Front Cell Dev Biol. 2021; 9:713499.
PMID: 34513842
PMC: 8427613.
DOI: 10.3389/fcell.2021.713499.
The Paratuberculosis Paradigm Examined: A Review of Host Genetic Resistance and Innate Immune Fitness in subsp. Infection.
Kravitz A, Pelzer K, Sriranganathan N
Front Vet Sci. 2021; 8:721706.
PMID: 34485444
PMC: 8414637.
DOI: 10.3389/fvets.2021.721706.
Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.
Li X, Liu L, Zhang J, Ma M, Sun L, Li X
Sci China Life Sci. 2021; 64(9):1379-1391.
PMID: 34351567
DOI: 10.1007/s11427-021-1965-x.
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer.
Graf R, Eskander R, Brueggeman L, Stupack D
JAMA Netw Open. 2021; 4(6):e2114162.
PMID: 34181012
PMC: 8239953.
DOI: 10.1001/jamanetworkopen.2021.14162.
MYC Copy Number Detection in Clinical Samples Using a Digital DNA-Hybridization and Detection Method.
Ogbah Z, Mancuso F, Vivancos A
Methods Mol Biol. 2021; 2318:321-336.
PMID: 34019300
DOI: 10.1007/978-1-0716-1476-1_18.
Evaluation of tools for identifying large copy number variations from ultra-low-coverage whole-genome sequencing data.
Smolander J, Khan S, Singaravelu K, Kauko L, Lund R, Laiho A
BMC Genomics. 2021; 22(1):357.
PMID: 34000988
PMC: 8130438.
DOI: 10.1186/s12864-021-07686-z.
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's Esophagus.
Gotovac J, Kader T, Milne J, Fujihara K, Lara-Gonzalez L, Gorringe K
Cell Mol Gastroenterol Hepatol. 2021; 12(2):689-713.
PMID: 33774196
PMC: 8267443.
DOI: 10.1016/j.jcmgh.2021.03.008.
Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer.
Nguyen B, Wong N, Semple T, Clark M, Wong S, Leslie C
Sci Rep. 2021; 11(1):4016.
PMID: 33597619
PMC: 7889887.
DOI: 10.1038/s41598-021-83436-1.
Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.
Nachmanson D, Steward J, Yao H, Officer A, Jeong E, OKeefe T
BMC Med Genomics. 2020; 13(1):173.
PMID: 33208147
PMC: 7672910.
DOI: 10.1186/s12920-020-00820-y.
Performance of Automated Dissection on Formalin-Fixed Paraffin-Embedded Tissue Sections for the 21-Gene Recurrence Score Assay.
Qi P, Bai Q, Yao Q, Yang W, Zhou X
Technol Cancer Res Treat. 2020; 19:1533033820960760.
PMID: 33073677
PMC: 7592317.
DOI: 10.1177/1533033820960760.
The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
Toss M, Abidi A, Lesche D, Joseph C, Mahale S, Saunders H
Br J Cancer. 2020; 122(10):1496-1506.
PMID: 32203210
PMC: 7217899.
DOI: 10.1038/s41416-020-0797-7.
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma.
Kader T, Elder K, Zethoven M, Semple T, Hill P, Goode D
NPJ Breast Cancer. 2020; 6:9.
PMID: 32195332
PMC: 7067788.
DOI: 10.1038/s41523-020-0150-6.
Screening of triploid with low-coverage whole-genome sequencing by a single-nucleotide polymorphism-based test in miscarriage tissue.
Geng Q, Cui X, Zhang Y, Zhang L, Zhang C, Wang K
J Assist Reprod Genet. 2019; 36(12):2525-2531.
PMID: 31720905
PMC: 6910887.
DOI: 10.1007/s10815-019-01588-6.
SMURF-seq: efficient copy number profiling on long-read sequencers.
Prabakar R, Xu L, Hicks J, Smith A
Genome Biol. 2019; 20(1):134.
PMID: 31287019
PMC: 6615205.
DOI: 10.1186/s13059-019-1732-1.
Effectiveness of a genetic test panel designed for gynecological cancer: an exploratory study.
Ida K, Miyamoto T, Higuchi S, Takeuchi H, Yamada S, Ono M
Med Oncol. 2019; 36(7):62.
PMID: 31139954
DOI: 10.1007/s12032-019-1286-9.